Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
xC8TEupXLNUxupqz
